Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction

The majority of cancer patients loses weight and becomes malnourished during the course of their disease. Metabolic alterations and reduced immune competence lead to wasting and an increased risk of infectious complications. In the present study, the effect of a nutritionally complete medical food, which is high in protein and leucine and enriched with fish oil and specific oligosaccharides, was investigated on immune function, nutritional status, and inflammation in patients with esophageal cancer and compared with routine care.

[1]  T. Reiman,et al.  Aberrations in Plasma Phospholipid Fatty Acids in Lung Cancer Patients , 2012, Lipids.

[2]  R. Wolfe,et al.  Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food. , 2011, Clinical nutrition.

[3]  P. Calder,et al.  Supplementation with a fish oil-enriched, high-protein medical food leads to rapid incorporation of EPA into white blood cells and modulates immune responses within one week in healthy men and women. , 2011, The Journal of nutrition.

[4]  P. Serafini.  Editorial: PGE2‐producing MDSC: a role in tumor progression? , 2010, Journal of leukocyte biology.

[5]  T. Reiman,et al.  Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients. , 2010, The Journal of nutrition.

[6]  S. Anker,et al.  Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle , 2010, Journal of cachexia, sarcopenia and muscle.

[7]  R. DuBois,et al.  Eicosanoids and cancer , 2010, Nature Reviews Cancer.

[8]  T. Lawrence,et al.  The resolution of inflammation and cancer. , 2010, Cytokine & growth factor reviews.

[9]  J. Garssen,et al.  Impaired immune function: an early marker for cancer cachexia. , 2009, Oncology reports.

[10]  D. McMillan.  Systemic inflammation, nutritional status and survival in patients with cancer , 2009, Current opinion in clinical nutrition and metabolic care.

[11]  P. Sinha,et al.  Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1 , 2009, The Journal of Immunology.

[12]  J. Argilés,et al.  Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice , 2009, British Journal of Cancer.

[13]  P. Vos,et al.  Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia , 2008, British Journal of Cancer.

[14]  N. Magné,et al.  Nutritional support during oncologic treatment of patients with gastrointestinal cancer: who could benefit? , 2008, Cancer treatment reviews.

[15]  P. Calder,et al.  Prebiotics, immune function, infection and inflammation: a review of the evidence. , 2008, The British journal of nutrition.

[16]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[17]  S. Shaikh,et al.  Polyunsaturated fatty acids and membrane organization: elucidating mechanisms to balance immunotherapy and susceptibility to infection. , 2008, Chemistry and physics of lipids.

[18]  J. Djeu,et al.  Mechanism and therapeutic reversal of immune suppression in cancer. , 2007, Cancer research.

[19]  A. Dalgleish,et al.  Review article: immune suppression and colorectal cancer , 2006, Alimentary pharmacology & therapeutics.

[20]  P. Calder,et al.  n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.

[21]  H. Kraemer,et al.  Improving methods of assessing natural killer cell cytotoxicity , 2006, International journal of methods in psychiatric research.

[22]  A. Ben-Baruch.  Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. , 2006, Seminars in cancer biology.

[23]  C. Lamers,et al.  Parallel detection of transduced T lymphocytes after immunogene therapy of renal cell cancer by flow cytometry and real-time polymerase chain reaction: implications for loss of transgene expression. , 2005, Human gene therapy.

[24]  P. Calder,et al.  Markers to measure immunomodulation in human nutrition intervention studies , 2005, British Journal of Nutrition.

[25]  J. Hadden.  Immunodeficiency and cancer: prospects for correction. , 2003, International immunopharmacology.

[26]  P. Dagnelie,et al.  Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. , 2002, Clinical nutrition.

[27]  J. Ross,et al.  Eicosanoid-dependent cancer cachexia and wasting , 2002, Current opinion in clinical nutrition and metabolic care.

[28]  H. Yamamori,et al.  Perioperative supplementation of EPA reduces immunosuppression induced by postoperative chemoradiation therapy in patients with esophageal cancer. , 2001, Nutrition.

[29]  G. Nitenberg,et al.  Nutritional support of the cancer patient: issues and dilemmas. , 2000, Critical reviews in oncology/hematology.

[30]  S. Takeuchi,et al.  Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients , 1999, Cancer Immunology, Immunotherapy.

[31]  W. Sano,et al.  Changes in immune function following surgery for esophageal carcinoma. , 1999, Nutrition.

[32]  K. Cheng,et al.  Classification of adenocarcinoma of the oesophagogastric junction , 1999, The British journal of surgery.

[33]  W. Sano,et al.  Effects of soybean oil emulsion and eicosapentaenoic acid on stress response and immune function after a severely stressful operation. , 1999, Annals of surgery.

[34]  S. Meydani,et al.  n-3 Polyunsaturated fatty acids and immune function , 1998, Proceedings of the Nutrition Society.

[35]  T. Kawano,et al.  Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. , 1997, Journal of clinical gastroenterology.

[36]  A. Laviano,et al.  Nutritional issues in cancer management. , 1996, Nutrition.

[37]  M. R. Young.  Eicosanoids and the immunology of cancer , 1994, Cancer and Metastasis Reviews.

[38]  N. Vakil,et al.  A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. , 1993, The New England journal of medicine.

[39]  M. Tisdale,et al.  Mechanism of muscle protein degradation in cancer cachexia. , 1993, British Journal of Cancer.

[40]  W. van Putten,et al.  Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes. , 1991, Cancer research.

[41]  T. Saito,et al.  Factors related to malnutrition in patients with esophageal cancer. , 1991, Nutrition.

[42]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[43]  C. Begg,et al.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. , 1980, The American journal of medicine.

[44]  Joseph R. Bertino,et al.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. , 1980, The American journal of medicine.

[45]  Murray Ac.  Some questions about drugs frequently asked of the Food and Drug Administration. , 1948 .

[46]  D. I. Givens,et al.  Fatty Acid Composition , 2016 .

[47]  M. Muscaritoli,et al.  New strategies to overcome cancer cachexia: from molecular mechanisms to the 'Parallel Pathway'. , 2008, Asia Pacific journal of clinical nutrition.

[48]  J. Garssen,et al.  Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates. , 2007, Critical reviews in immunology.

[49]  R. Bellantone,et al.  Prevention and treatment of cancer cachexia: new insights into an old problem. , 2006, European journal of cancer.

[50]  J. Argilés,et al.  Cancer-associated malnutrition. , 2005, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[51]  E. Van Cutsem,et al.  The causes and consequences of cancer-associated malnutrition. , 2005, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[52]  M. A. E. van Bokhorst-de van der Schueren.  Nutritional support strategies for malnourished cancer patients. , 2005, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[53]  M. Schueren.  Nutritional support strategies for malnourished cancer patients , 2005 .

[54]  K. Fearon,et al.  Cancer cachexia. , 1999, Surgical oncology.

[55]  Center for Food Safety and Applied Nutrition. , 1997, Nutrition reviews.

[56]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.